Effect of hyperbaric oxygen on chemotherapy-induced neuropathy in male and female rats. | Canada Hyperbarics Skip to main content
Clinical Study Behavioural pharmacology 2020

Effect of hyperbaric oxygen on chemotherapy-induced neuropathy in male and female rats.

Brewer AL, Shirachi DY, Quock RM, Craft RM — Behavioural pharmacology, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the effect of hyperbaric oxygen (HBO2) on chemotherapy-induced peripheral neuropathy in male and female rats previously treated with paclitaxel.

What They Found

Paclitaxel induced significant mechanical allodynia in both male and female rats, which was completely reversed by either one or four hyperbaric oxygen treatments. While female rats exhibited greater cold allodynia scores than males, HBO2 treatment did not reliably reduce these scores, and neither paclitaxel nor HBO2 affected locomotor behavior or estrous cycling.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.

Study Limitations

This study was conducted in rats, meaning its findings may not directly translate to human patients and require further clinical investigation.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 31503072
Year Published 2020
Journal Behavioural pharmacology
MeSH Terms Animals; Antineoplastic Agents; Behavior, Animal; Disease Models, Animal; Female; Hyperalgesia; Hyperbaric Oxygenation; Male; Neuralgia; Oxygen; Pain Measurement; Rats; Rats, Sprague-Dawley

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology